Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection

New England Journal of Medicine

Volumn 352, Issue 7, 2005, Pages 676-685

  Golden, Matthew R ^a,b   Whittington, William L H ^a   Handsfield, H Hunter ^a,b   Hughes, James P ^a   Stamm, Walter E ^a   Hogben, Matthew ^c   Clark, Agnes ^b   Malinski, Cheryl ^b   Helmers, Jennifer R L ^b   Thomas, Katherine K ^a   Holmes, King K ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Pub Health Seattle and King County   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHLAMYDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GONORRHEA; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT REFERRAL; PERSISTENT INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; RISK FACTOR; SEXUAL BEHAVIOR;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CEFIXIME; CHLAMYDIA INFECTIONS; CONTACT TRACING; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GONORRHEA; HETEROSEXUALITY; HUMANS; MALE; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; RECURRENCE; RISK FACTORS; SEXUAL PARTNERS;

EID: 13744261333     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa041681     Document Type: Article

References (26)

1. Parran T. Shadow on the land: syphilis. New York: Reynal & Hitchcock, 1937.
2. St Lawrence JS, Montano DE, Kasprzyk D, Phillips WR, Armstrong K, Leichliter JS. STD screening, testing, case reporting, and clinical and partner notification practices: a national survey of US physicians. Am J Public Health 2002;92:1784-8.
3. Golden MR, Hogben M, Handsfield HH, St Lawrence JS, Potterat JJ, Holmes KK. Partner notification for HIV and STD in the United States: low coverage for gonorrhea, chlamydial infection, and HIV. Sex Transm Dis 2003;30:490-6.
4. Potterat JJ, Rothenberg R. The case-finding effectiveness of self-referral system for gonorrhea: a preliminary report. Am J Public Health 1977;67:174-6.
5. Woodhouse DE, Potterat JJ, Muth JB, Pratts CI, Rothenberg RB. Fogle JS II. A civilian-military partnership to reduce the incidence of gonorrhea. Public Health Rep 1985;100:61-5.
6. Oh MK, Boker JR, Genuardi FJ, Cloud GA, Reynolds J, Hodgens JB. Sexual contact tracing outcome in adolescent chlamydial and gonococcal cervicitis cases. J Adolesc Health 1996;18:4-9.
7. Golden MR, Whittington WL, Handsfield HH, et al. Partner management for gonococcal and chlamydial infection: expansion of public health services to the private sector and expedited sex partner treatment through a partnership with commercial pharmacies. Sex Transm Dis 2001;28:658-65.
8. Fortenberry JD, Brizendine EJ, Katz BP, Orr DP. The role of self-efficacy and relationship quality in partner notification by adolescents with sexually transmitted infections. Arch Pediatr Adolesc Med 2002;156:1133-7.
9. Orr DP, Langefeld CD, Katz BP, Caine VA. Behavioral intervention to increase condom use among high-risk female adolescents. J Pediatr 1996;128:288-95.
10. Kjaer HO, Dimcevski G, Hoff G, Olesen F, Ostergaard L. Recurrence of urogenital Chlamydia trachomatis infection evaluated by mailed samples obtained at home: 24 weeks' prospective follow up study. Sex Transm Infect 2000;76:169-72.
11. Whittington WL, Kent C, Kissinger P, et al. Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex Transm Dis 2001;28:117-23.
12. Schillinger JA, Kissinger P, Calvet H, et al. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis 2003;30:49-56.
13. Fortenberry JD, Brizendine EJ, Katz BP, Wools KK, Blythe MJ, Orr DP. Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis. Sex Transm Dis 1999;26:26-32.
14. Hethcote HW, York JA. Gonorrhea transmission dynamics and control. New York: Springer-Verlag, 1984.
15. Kretzschmar M, van Duynhoven YT, Severijnen AJ. Modeling prevention strategies for gonorrhea and Chlamydia using stochastic network simulations. Am J Epidemiol 1996;144:306-17.
16. Macke BA, Maher JE. Partner notification in the United States: an evidence-based review. Am J Prev Med 1999;17:230-42.
17. Golden MR, Whittington WL, Gorbach PM, Coronado N, Boyd MA, Holmes KK. Partner notification for chlamydial infections among private sector clinicians in Seattle-King County: a clinician and patient survey. Sex Transm Dis 1999;26:543-7.
18. Klausner JD, Chaw JK. Patient-delivered therapy for chlamydia: putting research into practice. Sex Transm Dis 2003;30:509-11.
19. Ramstedt K, Forssman L, Johannisson G. Contact tracing in the control of genital Chlamydia trachomatis infection. Int J STD AIDS 1991;2:116-8.
20. Kissinger P, Brown R, Reed K, et al. Effectiveness of patient delivered partner medication for preventing recurrent Chlamydia trachomatis. Sex Transm Infect 1998;74:331-3.
21. Wacholder S. Binomial regression in GLIM: estimating risk ratios and risk differences. Am J Epidemiol 1986;123:174-84.
22. Martin DH, Mroczkowski TF, Dalu ZA, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. N Engl J Med 1992;327:921-5.
23. McCormack WM, Dalu ZA, Martin DH, et al. Double-blind comparison of trovafloxacin and doxycycline in the treatment of uncomplicated Chlamydial urethritis and cervicitis. Sex Transm Dis 1999;26:531-6.
24. Ruden AK, Jonsson A, Lidbrink P, Allebeck P, Bygdeman SM. Endemic versus non-endemic gonorrhoea in Stockholm: results of contact tracing. Int J STD AIDS 1993;4:284-92.
25. David LM, Wade AA, Natin D, Radcliffe KW. Gonorrhoea in Coventry 1991-1994: epidemiology, coinfection and evaluation of partner notification in the STD clinic. Int J STD AIDS 1997;8:311-6.
26. Oral alternatives to cefixime for the treatment of uncomplicated Neisseria gonorrhoeae urogenital infections. Atlanta: Centers for Disease Control and Prevention, 2004. (Accessed January 21, 2005, at http://www.cdc. gov/STD/treatment/Cefixime.htm.)